PMDA drug package insert
カネドリン顆粒
PMDA OTC drug · 株式会社 廣昌堂 · package insert Sep 11, 2021
Key facts
| Brand names | カネドリン顆粒 |
|---|---|
| Companies | 製造販売元／株式会社 廣昌堂 |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | 鎮咳去痰薬 |
| Package insert date | Sep 11, 2021 |
| PMDA document key | 270036_K1805000017 |
| PMDA company code | 270036 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: